# DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence

> **NCT03397771** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ixaltis SA** · enrollment: 84 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** Litoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03397771
- **Lead sponsor:** Ixaltis SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-03
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-05-30
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397771, "DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03397771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*